Composition

Each 1 ml contains:

• Tylosin tartrate: 300 mg

Pharmaceutical Form

Clear to amber-colored intramuscular injectable solution

Pharmacological Properties

Tylosin is a macrolide antibiotic produced by Streptomyces fradiae. It exhibits broad-spectrum activity primarily against Gram-positive bacteria, certain Gram-negative organisms, Mycoplasma species, some spirochetes, and large viruses. Its efficacy and long-acting formulation make it an ideal choice for managing a wide range of bacterial infections in veterinary medicine.

Target Species

Cattle, sheep, goats, poultry, dogs, and cats

Indications for Use

Cattle:

• Respiratory infections caused by Pasteurella multocida and Corynebacterium pyogenes
• Foot rot (necrotic pododermatitis)
• Diphtheria due to Fusobacterium necrophorum
• Metritis and acute mastitis caused by Streptococcus or Staphylococcus species

Sheep and goats:

• Caprine pleuropneumonia caused by Mycoplasma mycoides

Dogs and cats:

• Upper respiratory tract infections: tracheobronchitis, bronchitis, laryngitis, tracheitis
• Feline pneumonitis, cellulitis, pneumonia
• Otitis externa, metritis, tonsillitis
• Interdigital cysts, leptospirosis
• Secondary bacterial infections associated with viral diseases
• Supportive treatment during surgical procedures or post-injury infections

Poultry:

• Effective for Mycoplasma-related respiratory infections when administered subcutaneously

Contraindications

• Do not mix with other injectable solutions to prevent precipitation
• Not to be used in horses or other equine species (may cause death)
• Contraindicated in lactating cattle
• Not suitable for poultry producing eggs for human consumption

Undesirable Effects

No adverse effects reported when used as directed

Posology and Method of Administration

Administer via intramuscular injection as follows:

• Cattle, camels, sheep, goats: 0.5–1.0 ml per 20 kg body weight once daily for up to 5 days
• Dogs and cats: 0.1–0.5 ml per 10 kg body weight once daily
• Poultry: 25 mg/kg body weight, administered subcutaneously once

Overdose

No specific adverse effects have been observed. Follow recommended dosing guidelines.

Withdrawal Period

• Animals should not be slaughtered for human consumption within 21 days of the last treatment
• Not for use in dairy animals producing milk for human consumption

Special Safety Precautions for the Person Administering the Product

No special precautions required beyond standard injection safety procedures

Special Precautions for Storage

Store in a dry place below 30°C.
Do not refrigerate.

Nature of the Product

Pale yellow to amber-colored sterile solution

Packaging

Available in 50 ml and 100 ml glass vials

For veterinary use only. Consult a veterinarian before use.